Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Balu

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Progress in Molecular Biology and Translational Science|February 3, 2009
Folding considerations for therapeutic protein formulationsLioubov G Korotchkina, Karthik Ramani, Sathy V Balu-Iyer
International Journal of Cardiology|February 1, 1984
Effect of left ventricular aneurysmectomy on exercise performanceV Balu, N Hook, D C Dean, et al.
The AAPS Journal|June 3, 2010
Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a miceAaron Peng, Robert M Straubinger, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|November 6, 2017
Lipidic Nanoparticles Comprising Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe DiseaseJennifer L Schneider, Robert K Dingman, Sathy V Balu-Iyer
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Tolerogenic form of Factor VIII to prevent inhibitor development in the treatment of Hemophilia ANhan H Nguyen, Robert K Dingman, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|January 6, 2010
Delivery of therapeutic proteinsDipak S Pisal, Matthew P Kosloski, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|October 28, 2011
Influence of route of administration and liposomal encapsulation on blood and lymph node exposure to the protein VEGF-C156SSuraj G Bhansali, Sathy V Balu-Iyer, Marilyn E Morris
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1977
Assessment of cardiac risk in surgical patientsA A Gage, J N Bhayana, V Balu, et al.
The AAPS Journal|June 6, 2009
Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIIIMatthew P Kosloski, Razvan D Miclea, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|May 23, 2023
Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A TherapiesNhan H Nguyen, Nicole L Jarvi, Sathy V Balu-Iyer
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Progress in Molecular Biology and Translational Science|February 3, 2009
Folding considerations for therapeutic protein formulationsLioubov G Korotchkina, Karthik Ramani, Sathy V Balu-Iyer
International Journal of Cardiology|February 1, 1984
Effect of left ventricular aneurysmectomy on exercise performanceV Balu, N Hook, D C Dean, et al.
The AAPS Journal|June 3, 2010
Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a miceAaron Peng, Robert M Straubinger, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|November 6, 2017
Lipidic Nanoparticles Comprising Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe DiseaseJennifer L Schneider, Robert K Dingman, Sathy V Balu-Iyer
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Tolerogenic form of Factor VIII to prevent inhibitor development in the treatment of Hemophilia ANhan H Nguyen, Robert K Dingman, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|January 6, 2010
Delivery of therapeutic proteinsDipak S Pisal, Matthew P Kosloski, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|October 28, 2011
Influence of route of administration and liposomal encapsulation on blood and lymph node exposure to the protein VEGF-C156SSuraj G Bhansali, Sathy V Balu-Iyer, Marilyn E Morris
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1977
Assessment of cardiac risk in surgical patientsA A Gage, J N Bhayana, V Balu, et al.
The AAPS Journal|June 6, 2009
Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIIIMatthew P Kosloski, Razvan D Miclea, Sathy V Balu-Iyer
Journal of Pharmaceutical Sciences|May 23, 2023
Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A TherapiesNhan H Nguyen, Nicole L Jarvi, Sathy V Balu-Iyer
Pageof 8